Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy

Drugs targeting heat shock protein 90 (Hsp90) have been extensively explored for their anticancer potential in advanced clinical trials. Nanoformulations have been an important drug delivery platform for the anticancer molecules like Hsp90 inhibitors. It has been reported that bovine serum albumin (...

Descripción completa

Detalles Bibliográficos
Autores principales: K. Rochani, Ankit, Balasubramanian, Sivakumar, Ravindran Girija, Aswathy, Maekawa, Toru, Kaushal, Gagan, Kumar, D. Sakthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465148/
https://www.ncbi.nlm.nih.gov/pubmed/32796651
http://dx.doi.org/10.3390/polym12081798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465148/
https://www.ncbi.nlm.nih.gov/pubmed/32796651
http://dx.doi.org/10.3390/polym12081798

Ejemplares similares